Citations

Showing 10 of 108094 citations.

Prognostic factors for human papillomavirus–positive and negative oropharyngeal carcinomas
Yin, Linda X. , DʼSouza, Gypsyamber , Westra, William H. , Wang, Steven J. , Zante, Annemieke van , Zhang, Yuehan , Rettig, Eleni M. , Ryan, William R. , Ha, Patrick K. , Wentz, Alicia, Koch, Wayne M. , Eisele, David W. , Fakhry, Carole , Koch, Wayne , Yin, Linda X

Mayo Clinic

The Laryngoscope | March 15, 2018 | Volume: 128 | Issue: 8 | Pages: No page available

10.1002/lary.27130 | PMID 29536542 Get It

Objectives/HypothesisHuman papillomavirus (HPV)‐positive and HPV‐negative oropharyngeal squamous cell carcinoma (OPSCC) are distinct disease entities. Prognostic factors specific to each entity have not been adequately explored. Goals for this study were: 1) to determine whether HPV‐positive and HPV‐negative OPSCCs have distinct prognostic factors, and 2) to explore the prognostic significance of sex and race in OPSCC after HPV stratificationStudy DesignRetrospective case series.MethodsA retrospective review of 239 incident OPSCC patients from 1995 to 2012, treated at Johns Hopkins and University of California–San Francisco was conducted. Women and nonwhite races were oversampled. All analyses were stratified by tumor HPV in situ hybridization status. The effects of sex and race on survival were considered in Kaplan‐Meier and unadjusted and adjusted Cox regression models.ResultsOne hundred thirty‐four (56.1%) OPSCC patients were HPV positive. On univariate analysis, women had better overall survival than men among HPV‐positive (hazard ratio [HR]: 0.47, 95% confidence interval [CI]: 0.20‐1.07; P = .06) but not HPV‐negative (HR: 0.73, 95% CI: 0.43‐1.24; P = .24) OPSCCs. On multivariate analysis, women with HPV‐positive OPSCCs remained at lower risk of death (adjusted hazard ratio [aHR]: 0.34, 95% CI: 0.12‐0.96; P = .04). Survival did not vary significantly by race among HPV‐positive patients. Among HPV‐negative patients, Hispanic patients had significantly better survival in unadjusted (HR: 0.27, 95% CI: 0.08‐0.91; P = .04) but not adjusted (aHR: 0.93, 95% CI: 0.11‐7.36; P = .94) analysis.ConclusionsWomen with HPV‐positive OPSCC may have improved overall survival compared to men. Sex does not play a prognostic role in HPV‐negative OPSCC. There are no differences in prognosis by race among HPV‐positive or HPV‐negative patients.Level of Evidence4 Laryngoscope, E288–E296, 2018
Lightweight, compact, and high‐performance 3T MR system for imaging the brain and extremities
Foo, Thomas , Laskaris, E.T., Vermilyea, Mark, Xu, Minfeng , Thompson, Paul, Conte, Gene, Epps, Christopher Van, Immer, Christopher, Tan, Ek T. , Graziani, Dominic, Mathieu, Jean‐Baptise, Hardy, Christopher J., Schenck, John F., Fiveland, Eric, Stautner, Wolfgang , Ricci, Justin, Piel, Joseph E., Park, Keith, Hua, Yihe , Bai, Ye , Kagan, Alex, Stanley, David A. , Weavers, Paul T., Gray, Erin M. , Shu, Yunhong , Frick, Matthew A., Trzasko, Joshua D. , Foo, Thomas K F , Tan, Ek T , Gray, Erin, Trzasko, Joshua, Bernstein, Matt A , Thompson, Paul, Epps, Chris Van, Lee, Seung‐Kyun , Campeau, Norbert G. , Huston, John , Bernstein, Matt A.

Mayo Clinic

Magnetic Resonance in Medicine | March 15, 2018 | Volume: 80 | Issue: 5 | Pages: 2232-2245

10.1002/mrm.27175 | PMID 29536587 Get It

PurposeTo build and evaluate a small‐footprint, lightweight, high‐performance 3T MRI scanner for advanced brain imaging with image quality that is equal to or better than conventional whole‐body clinical 3T MRI scanners, while achieving substantial reductions in installation costs.MethodsA conduction‐cooled magnet was developed that uses less than 12 liters of liquid helium in a gas‐charged sealed system, and standard NbTi wire, and weighs approximately 2000 kg. A 42‐cm inner‐diameter gradient coil with asymmetric transverse axes was developed to provide patient access for head and extremity exams, while minimizing magnet‐gradient interactions that adversely affect image quality. The gradient coil was designed to achieve simultaneous operation of 80‐mT/m peak gradient amplitude at a slew rate of 700 T/m/s on each gradient axis using readily available 1‐MVA gradient drivers.ResultsIn a comparison of anatomical imaging in 16 patients using T2‐weighted 3D fluid‐attenuated inversion recovery (FLAIR) between the compact 3T and whole‐body 3T, image quality was assessed as equivalent to or better across several metrics. The ability to fully use a high slew rate of 700 T/m/s simultaneously with 80‐mT/m maximum gradient amplitude resulted in improvements in image quality across EPI, DWI, and anatomical imaging of the brain.ConclusionsThe compact 3T MRI system has been in continuous operation at the Mayo Clinic since March 2016. To date, over 200 patient studies have been completed, including 96 comparison studies with a clinical 3T whole‐body MRI. The increased gradient performance has reliably resulted in consistently improved image quality.
Prevalence and survival of smouldering Waldenström macroglobulinaemia in the United States
Pophali, Priyanka A. , Bartley, Adam C. , Kapoor, Prashant , Gonsalves, Wilson I. , Ashrani, Aneel A. , Marshall, Ariela L. , Siddiqui, Mustaqeem , Kyle, Robert A. , Bartley, Adam, Siddiqui, Mustaqeem A, Gonsalves, Wilson , Marshall, Ariela , Siddiqui, Mustaqeem A , Pophali, Priyanka , Go, Ronald S.

Mayo Clinic

British Journal of Haematology | March 15, 2018 | Volume: 184 | Issue: 6 | Pages: 1014-1017

10.1111/bjh.15201 | PMID 29532912 Get It

Epidemiology of general anesthesia prior to age 3 in a population‐based birth cohort
Shi, Yu , Hu, Danqing , Rodgers, Erin L., Katusic, Slavica K., Gleich, Stephen J. , Hanson, Andrew C. , Schroeder, Darrell R. , Flick, Randall P., Schroeder, Darrell , Warner, David O.

Mayo Clinic

Pediatric Anesthesia | March 15, 2018 | Volume: 28 | Issue: 6 | Pages: 513-519

10.1111/pan.13359 | PMID 29532559 Get It

SummaryBackgroundUtilization of general anesthesia in children has important policy, economic, and healthcare delivery implications, yet there is little information regarding the epidemiology of these procedures in the United States.AimsThe primary objective of this study was to describe in a geographically defined population the incidence of procedures requiring general anesthesia up to the child's third birthday, and the patient characteristics associated with receiving these procedures. A secondary objective was to determine the proportion of children in the population who meet the risk criteria promulgated by the Food and Drug Administration (FDA).MethodsA retrospective cohort of children born from 1994 to 2007 in Olmsted County, MN was established. Birth certificate information and receipt of general anesthesia before age 3 were collected. Proportional hazard regressions were performed to evaluate the association between characteristics of children and incidence of general anesthesia.ResultsAmong the 20 922 children in the cohort, 3120 (14.9%) underwent at least 1 general anesthesia before age 3. In multivariate regression, factors independently associated with receiving at least 1 procedure included prematurity, male sex, lower birth weight, cesarean delivery, a non‐Hispanic mother, and a White mother, controlling for multiple gestation, number of children previously born, age, education, and marital status of the mother. Seven hundred and twenty‐three children (3.5%) had at least 1 subsequent procedure. Estimated gestational age <32 weeks and low birth weight were independently associated with receiving repeated anesthesia. Eight hundred and twenty children (3.9%) had a single prolonged exposure above 3 hours, multiple exposures prior to age 3, or both.ConclusionApproximately 1 in 7 children were exposed to at least 1 episode of general anesthesia before age 3, and approximately 1 in 4 children who received general anesthesia fall within the high‐risk category as defined by the recent FDA warning. The apparent disparities in surgical utilization related to race and ethnicity in this study population deserve further exploration.
Image‐guided radiotherapy quality control: Statistical process control using image similarity metrics
Shiraishi, Satomi , Santos, Luis E. Fong de los, Grams, Michael P. , Fong de Los Santos, Luis E, Shiraishi, Satomi

Mayo Clinic

Medical Physics | March 15, 2018 | Volume: 45 | Issue: 5 | Pages: 1811-1821

10.1002/mp.12859 | PMID 29532493 Get It

PurposeThe purpose of this study was to demonstrate an objective quality control framework for the image review process.Methods and materialsA total of 927 cone‐beam computed tomography (CBCT) registrations were retrospectively analyzed for 33 bilateral head and neck cancer patients who received definitive radiotherapy. Two registration tracking volumes (RTVs) — cervical spine (C‐spine) and mandible — were defined, within which a similarity metric was calculated and used as a registration quality tracking metric over the course of treatment. First, sensitivity to large misregistrations was analyzed for normalized cross‐correlation (NCC) and mutual information (MI) in the context of statistical analysis. The distribution of metrics was obtained for displacements that varied according to a normal distribution with standard deviation of σ = 2 mm, and the detectability of displacements greater than 5 mm was investigated. Then, similarity metric control charts were created using a statistical process control (SPC) framework to objectively monitor the image registration and review process. Patient‐specific control charts were created using NCC values from the first five fractions to set a patient‐specific process capability limit. Population control charts were created using the average of the first five NCC values for all patients in the study. For each patient, the similarity metrics were calculated as a function of unidirectional translation, referred to as the effective displacement. Patient‐specific action limits corresponding to 5 mm effective displacements were defined. Furthermore, effective displacements of the ten registrations with the lowest similarity metrics were compared with a three dimensional (3DoF) couch displacement required to align the anatomical landmarks.ResultsNormalized cross‐correlation identified suboptimal registrations more effectively than MI within the framework of SPC. Deviations greater than 5 mm were detected at 2.8σ and 2.1σ from the mean for NCC and MI, respectively. Patient‐specific control charts using NCC evaluated daily variation and identified statistically significant deviations. This study also showed that subjective evaluations of the images were not always consistent. Population control charts identified a patient whose tracking metrics were significantly lower than those of other patients. The patient‐specific action limits identified registrations that warranted immediate evaluation by an expert. When effective displacements in the anterior–posterior direction were compared to 3DoF couch displacements, the agreement was ±1 mm for seven of 10 patients for both C‐spine and mandible RTVs.ConclusionsQualitative review alone of IGRT images can result in inconsistent feedback to the IGRT process. Registration tracking using NCC objectively identifies statistically significant deviations. When used in conjunction with the current image review process, this tool can assist in improving the safety and consistency of the IGRT process.
Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients
Kalli, Kimberly R., Block, Matthew S. , Kasi, Pashtoon Murtaza , Erskine, Courtney L. , Hobday, Timothy J. , Dietz, Allan B. , Padley, Douglas, Gustafson, Michael P. , Shreeder, Barath , Puglisi-Knutson, Danell, Visscher, Dan W., Mangskau, Toni K., Wilson, G. Haswell , Knutson, Keith L. , Kasi, Pashtoon M, Dietz, Allan, Kasi, Pashtoon Murtaza , Dietz, Allan B , Knutson, Keith L.

Mayo Clinic

Clinical Cancer Research | March 15, 2018 | Volume: 24 | Issue: 13 | Pages: 3014-3025

10.1158/1078-0432.ccr-17-2499 | PMID 29545464 Get It

Abstract Purpose: Folate receptor alpha (FR) is overexpressed in several cancers. Endogenous immunity to the FR has been demonstrated in patients and suggests the feasibility of targeting FR with vaccine or other immune therapies. CD4 helper T cells are central to the development of coordinated immunity, and prior work shows their importance in protecting against relapse. Our previous identification of degenerate HLA-class II epitopes from human FR led to the development of a broad coverage epitope pool potentially useful in augmenting antigen-specific immune responses in most patients. Patients and Methods: We conducted a phase I clinical trial testing safety and immunogenicity of this vaccine, enrolling patients with ovarian cancer or breast cancer who completed conventional treatment and who showed no evidence of disease. Patients were initially treated with low-dose cyclophosphamide and then vaccinated 6 times, monthly. Immunity and safety were examined during the vaccine period and up to 1 year later. Results: Vaccination was well tolerated in all patients. Vaccine elicited or augmented immunity in more than 90% of patients examined. Unlike recall immunity to tetanus toxoid (TT), FR T-cell responses developed slowly over the course of vaccination with a median time to maximal immunity in 5 months. Despite slow development of immunity, responsiveness appeared to persist for at least 12 months. Conclusions: The results demonstrate that it is safe to augment immunity to the FR tumor antigen, and the developed vaccine is testable for therapeutic activity in most patients whose tumors express FR, regardless of HLA genotype. Clin Cancer Res; 24(13); 3014–25. ©2018 AACR.
Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice
Li, Shuang , Robinson, Jennifer G. , Roger, Véronique L. , Goldberg, Anne C. , Wilson, Peter W.F. , Lee, L. Veronica, Elassal, Joseph, Wang, Tracy Y., Virani, Salim, Návar, Ann Marie , Peterson, Eric D. , Virani, Salim S. , Nanna, Michael G.

Mayo Clinic

Circulation: Cardiovascular Quality and Outcomes | March 15, 2018 | Volume: 11 | Issue: 3 | Pages: No page available

10.1161/circoutcomes.117.004249 | PMID 29545393 Get It

Cluster Headache Clinical Phenotypes: Tobacco Nonexposed (Never Smoker and No Parental Secondary Smoke Exposure as a Child) versus Tobacco‐Exposed: Results from the United States Cluster Headache Survey
Rozen, Todd D.

Mayo Clinic

Headache: The Journal of Head and Face Pain | March 15, 2018 | Volume: 58 | Issue: 5 | Pages: 688-699

10.1111/head.13295 | PMID 29536529 Get It

Objective To present results from the United States Cluster Headache Survey comparing the clinical presentation of tobacco nonexposed and tobacco‐exposed cluster headache patients. Background Cluster headache is uniquely tied to a personal history of tobacco usage/cigarette smoking and, if the individual cluster headache sufferer did not smoke, it has been shown that their parent(s) typically did and that individual had significant secondary smoke exposure as a child. The true nontobacco exposed (no personal or secondary exposure) cluster headache sufferer has never been fully studied. Methods The United States Cluster Headache Survey consisted of 187 multiple choice questions related to cluster headache including: patient demographics, clinical headache characteristics, family history, triggers, smoking history (personal and secondary), and headache‐related disability. The survey was placed on a website from October through December 2008. Results One thousand one hundred thirty‐four individuals completed the survey. One hundred thirty‐three subjects or 12% of the surveyed population had no personal smoking/tobacco use history and no secondary smoke exposure as an infant/child, thus a nontobacco exposed population. In the nonexposed population, there were 87 males and 46 females with a gender ratio of 1.9:1. Episodic cluster headache occurred in 80% of nonexposed subjects. One thousand and one survey responders or 88% were tobacco‐exposed (729 males and 272 females) with a gender ratio of 2.7:1. Eighty‐three percent had a personal smoking history, while only 17% just had parents who smoked with secondary smoke exposure. Eighty‐five percent of smokers had double exposure with a personal smoking history and secondary exposure as a child. Significant highlights from the survey Nonexposed cluster headache subjects are significantly more likely to develop cluster headache at ages 40 years and younger, while the exposed sufferers are significantly more likely to develop cluster headache at 40 years of age and older. Nonexposed patients have a statistically significant higher frequency of a migraine family history. The exposed population is statistically significantly more likely to have a history of head trauma 19% vs the nonexposed population 10% ( P = .02). Tobacco exposed are significantly more likely to transition from episodic to chronic cluster headache (23% vs 14%, P = .02). Cranial autonomic symptoms as well as agitation are more common in tobacco exposed. Nonexposed are less likely to have specific cluster headache triggers. Exposed are significantly more likely to be triggered by alcohol. Tobacco exposed are significantly heavier caffeine users than nonexposed. Nonexposed are significantly more likely to have cluster headache cycles that vary throughout the year than exposed (52% vs 40%, P = .02). Exposed are much more likely to develop cluster headache from 12 am to 6 am than non exposed. Exposed experience significantly more frequent attacks per day and longer duration cycles than nonexposed. A significantly larger percent of the exposed population (57%) has suicidal ideations with their syndrome than nonexposed (43%) ( P = .003). In regard to disability, both subtypes are disabled by their headaches, but exposed have more work related disability and lost home‐days from headache. Both subgroups have a poor overall response to preventive and abortive medication outside of inhaled oxygen and injectable sumatriptan. Conclusion Cluster headache sufferers who were never exposed to tobacco (personal or secondary as a child) appear to present uniquely compared to the tobacco exposed subgroup. The tobacco exposed clinical phenotype appears to have a more severe syndrome based on attack frequency, cycle duration, and headache related disability. Tobacco exposure is associated with cluster headache chronification. The nonexposed subtype appears to have an earlier age of onset, higher rate of familial migraine, and less circadian periodicity and daytime entrainment, suggesting a possible different underlying pathology than in the tobacco exposed sub‐form.
Common Language Description of the Term Rheumatic and Musculoskeletal Diseases (RMDs) for Use in Communication With the Lay Public, Healthcare Providers, and Other Stakeholders Endorsed by the European League Against Rheumatism (EULAR
Daikh, David, Betteridge, Neil , Burmester, Gerd R , Hassett, Afton L. , Matteson, Eric L. , Vollenhoven, Ronald van , Lakhanpal, Sharad, Heijde, Désirée M F M van der , Burmester, Gerd-Rüdiger

Mayo Clinic

Arthritis & Rheumatology | March 15, 2018 | Volume: 70 | Issue: 6 | Pages: 826-831

10.1002/art.40448 | PMID 29532625 Get It

A European League Against Rheumatism–American College of Rheumatology working group consisting of practicing and academic rheumatologists, a rheumatology researcher, and a patient representative created a succinct general statement describing rheumatic and musculoskeletal diseases (RMDs) in adults and children in language that can be used in conversations with the lay public, media, healthcare providers, and other stakeholders. Based on the literature review, several elements were deemed important for inclusion in the description of RMDs. First, RMDs encompass many different diseases that can affect individuals at any age, including children. Second, there are various pathophysiological pathways underlying different RMDs. Third, the impact of RMDs on individuals and society should be emphasized. The working group agreed that the language should be comprehensible to the lay public. Thus, the following description of RMDs has been developed: “Rheumatic and musculoskeletal diseases (RMDs) are a diverse group of diseases that commonly affect the joints, but can affect any organ of the body. There are more than 200 different RMDs, affecting both children and adults. They are usually caused by problems of the immune system, inflammation, infections, or gradual deterioration of joints, muscles, and bones. Many of these diseases are long term and worsen over time. They are typically painful and limit function. In severe cases, RMDs can result in significant disability, having a major impact on both quality of life and life expectancy.” This description can be used by rheumatology groups, researchers, and those who work in advocacy and education related to RMDs.
Sex-Based Differences in Knee Kinetics With Anterior Cruciate Ligament Strain on Cadaveric Impact Simulations
Schilaty, Nathan D. , Bates, Nathaniel A. , Nagelli, Christopher V. , Krych, Aaron J. , Hewett, Timothy E. , Nagelli, Christopher, Krych, Aaron J , Schilaty, Nathan D , Bates, Nathaniel A

Mayo Clinic

Orthopaedic Journal of Sports Medicine | March 15, 2018 | Volume: 6 | Issue: 3 | Pages: No page available

10.1177/2325967118761037 | PMID 29568787 Get It

Background: Females are at an increased risk of sustaining noncontact knee ligament injuries as compared with their male counterparts. The kinetics that load the anterior cruciate ligament (ACL) are still under dispute in the literature. Purpose/Hypothesis: The purpose of this study was to determine whether there are differences in knee kinetics between the sexes that lead to greater ACL strain in females when similar external loads are applied during a simulated drop vertical jump landing task. It was hypothesized that female limbs would demonstrate significant differences in knee abduction moment that predispose females to ACL injury when compared with males. Study Design: Controlled laboratory study. Methods: Motion analysis data of 67 athletes who performed a drop vertical jump were collected. The kinematic and kinetic data were used to categorize tertiles of relative risk, and these values were input into a cadaveric impact simulator to assess ligamentous loads during the simulated landing task. Uni- and multiaxial load cells and differential variable reluctance transducer strain sensors were utilized to collect kinetic data and maximum ACL strain for analysis. Conditions of external loads applied to the cadaveric limbs were systematically varied and randomized. Data were analyzed with 2-way repeated-measures analysis of variance and the Fisher exact test. Results: Five kinetic parameters were evaluated. Of the 5 kinetic variables, only knee abduction moment (KAM) demonstrated significant differences in females as compared with males ( F 1,136 = 4.398, P = .038). When normalized to height and weight, this difference between males and females increased in significance ( F 1,136 = 7.155, P = .008). Compared with males, females exhibited a 10.3-N·m increased knee abduction torque at 66 milliseconds postimpact and a 22.3-N·m increased abduction torque at 100 milliseconds postimpact. For loading condition, the condition of “maximum ACL strain” demonstrated a maximum difference of 54.3-N·m increased abduction torque and 74.5-N·m increased abduction torque at 66 milliseconds postimpact. Conclusion: Under the tested conditions, increased external loads led to increased medial knee translation force, knee abduction moment, and external knee moment. Females exhibited greater forces and moments at the knee, especially at KAM, when loaded in similar conditions. As these KAM loads are associated with increased load and strain on the ACL, the sex-based differences observed in the present study may account for a portion of the underlying mechanics that predispose females to ACL injury as compared with males in a controlled simulated athletic task. Clinical Relevance: KAM increases strain to the ACL under clinically representative loading. Additionally, this work establishes the biomechanical characteristics of knee loading between sexes.